RP128 peptide-based radiopharmaceutical: Completed a European Phase I trial

Resolution Pharmaceuticals Inc., Mississauga, Ontario Product: RP128 peptide-based radiopharmaceutical Indication: Imaging of inflammation Status: Resolution, a joint venture between Allelix Biopharm...